The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled tri

Abstract:

:Cytochrome P450 (CYP) 2C19 genotype is closely associated with the metabolism and efficacy of clopidogrel, thereby having an important impact on clinical outcomes of patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). This study aimed to evaluate the efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy in patients with ACS or undergoing PCI. PubMed, EMBASE, the Cochrane Library and clinicaltrials.gov were searched to identify randomized controlled trials (RCTs) comparing CYP2C19 genotype-guided antiplatelet therapy with conventional therapy in patients with ACS or undergoing PCI. Eight RCTs involving 6708 patients were included in this meta-analysis. CYP2C19 genotype-guided antiplatelet therapy was slightly superior to the conventional antiplatelet therapy in reducing the risk of MACE [RR(95%CI): 0.71(0.51-0.98), p = .04]. Meanwhile, the genotype-guided therapy group had significantly lower incidence of myocardial infarction [RR(95%CI): 0.56(0.40-0.78), p < .01], but similar risk of all-cause mortality, cardiovascular mortality, stent thrombosis, urgent revascularization and stroke compared to the conventional therapy group. Incidences of major/minor bleeding and major bleeding were comparable between the two groups. In patients with ACS or undergoing PCI, CYP2C19 genotype-guided antiplatelet therapy displayed benefit over conventional antiplatelet therapy in reducing the risk of MACE and myocardial infarction, without increasing bleeding risk. Further RCTs are needed to provide more evidences for CYP2C19 genotype-guided antiplatelet therapy.

journal_name

Platelets

journal_title

Platelets

authors

Lyu SQ,Yang YM,Zhu J,Wang J,Wu S,Zhang H,Shao XH,Ren JM

doi

10.1080/09537104.2020.1780205

subject

Has Abstract

pub_date

2020-11-16 00:00:00

pages

971-980

issue

8

eissn

0953-7104

issn

1369-1635

journal_volume

31

pub_type

杂志文章
  • Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.

    abstract::Microparticles (MPs) are blebs released from cellular surfaces during activation/apoptosis. They are procoagulant, pro-inflammatory and could contribute to pathogenesis of deep venous thrombosis (DVT). This study compared the number, cellular origin and procoagulant activity of MPs on DVT patients in different clinica...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100903096676

    authors: Flores-Nascimento MC,Beltrame MP,De Paula EV,Montalvão SL,Pereira FG,Orsi FL,Lorand-Metze I,Annichino-Bizzacchi JM

    更新日期:2009-09-01 00:00:00

  • Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.

    abstract::The influence of three anti-platelet drugs, cilostazol, aspirin, and tirofiban, was investigated on platelet-leukocyte interaction by flow cytometry. When platelets and leukocytes were pre-incubated with anti-platelet drugs and stimulated by thrombin or collagen, cilostazol was found to inhibit platelet adhesion to mo...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100410001715583

    authors: Ito H,Miyakoda G,Mori T

    更新日期:2004-08-01 00:00:00

  • Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction.

    abstract::The MEK inhibitors cobimetinib and trametinib are used in combination with BRAF inhibitors to treat metastatic melanoma but increase rates of hemorrhage relative to BRAF inhibitors alone. Platelets express several members of the MAPK signalling cascade including MEK1 and MEK2 and ERK1 and ERK2 but their role in platel...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2018.1514107

    authors: Unsworth AJ,Bye AP,Kriek N,Sage T,Osborne AA,Donaghy D,Gibbins JM

    更新日期:2019-01-01 00:00:00

  • Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.

    abstract::Intracranial hemorrhage (ICH) is a devastating complication of immune thrombocytopenia (ITP). However, information on ICH in ITP patients under the age of 60 years is limited, and no predictive tools are available in clinical practice. A total of 93 adult patients with ITP who developed ICH before 60 years of age were...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1786042

    authors: Zhao P,Hou M,Liu Y,Liu HX,Huang RB,Yao HX,Niu T,Peng J,Jiang M,Han YQ,Hu JD,Zhou H,Zhou ZP,Qiu L,Zhang LS,Wang X,Wang HQ,Feng R,Yang LH,Ma LM,Wang SQ,Kong PY,Wang WS,Sun HP,Sun J,Zhou HB,Zhu TN,Wang

    更新日期:2020-07-02 00:00:00

  • Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia.

    abstract::We measured and compared the levels of microparticles, chemokines, cell adhesion molecules and platelet activation markers with a view to developing a better understanding of their potential contributions to the pathophysiology of progressive systemic sclerosis (PSS, scleroderma). The concentrations of all the factors...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701882038

    authors: Nomura S,Inami N,Ozaki Y,Kagawa H,Fukuhara S

    更新日期:2008-05-01 00:00:00

  • Effects of beta2-glycoprotein-I on platelet aggregation in cord versus adult whole blood.

    abstract::We present a peculiarity of the neonatal hemostatic system that might contribute to establish a procoagulant readiness in neonatal blood by sensitizing neonatal platelets for ADP stimulation. beta2-glycoprotein-I (beta2-GP-I) is a plasma constituent capable of suppressing ADP-induced platelet aggregation. We found sig...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100600800529

    authors: Cvirn G,Gallistl S,Koestenberger M,Kutschera J,Ferstl U,Kellner J,Jurgens G,Gries A

    更新日期:2007-02-01 00:00:00

  • Platelet activation in subjects with impaired glucose tolerance.

    abstract::Impaired glucose tolerance (IGT), a prediabetic state, is associated with an increased risk of cardiovascular disease. Mean platelet volume (MPV), a determinant of platelet activation, is a newly emerging risk factor for atherothrombosis. This study was designed to answer the following questions: (i) Do MPV levels cha...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701609019

    authors: Coban E,Kucuktag S,Basyigit S

    更新日期:2007-12-01 00:00:00

  • Platelet count and mortality of H7N9 infected patients in Guangdong, China.

    abstract::Avian influenza A (H7N9) is a serve zoonosis with a high mortality rate. Timely and effective diagnosis and early warning is crucial for the clinical treatment of H7N9 patients. The previous studies indicated that thrombocytopenia was associated with the prognosis of influenza cases, but the related evidence of platel...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2019.1665639

    authors: Chen Y,Yang Y,Cheng J,Lu J,Hu W

    更新日期:2020-01-01 00:00:00

  • Interactions of platelets with Synthocytes, a novel platelet substitute.

    abstract::A platelet substitute, Synthocytes, is being developed for the prevention and treatment of thrombocytopenia. Synthocytes are composed of fibrinogen adsorbed on heat stabilised albumin microcapsules of defined size. The purpose of this study was to perform experiments in vitro to investigate the capacity of Synthocytes...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/0953371027000

    authors: Davies AR,Judge HM,May JA,Glenn JR,Heptinstall S

    更新日期:2002-06-01 00:00:00

  • Platelet-rich plasma (PRP) and tendon healing: comparison between fresh and frozen-thawed PRP.

    abstract::Platelet-rich plasma (PRP) is increasingly used in the treatment of musculoskeletal diseases. Its preservation by freezing it for the realization of multiple injections in clinical use has never been discussed. Calcaneal tendons of rats were surgically sectioned. Platelet concentration of the PRP was 2.5 x 106/µl with...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2019.1595563

    authors: Kaux JF,Libertiaux V,Dupont L,Colige A,Denoël V,Lecut C,Hego A,Gustin M,Duwez L,Oury C,Gothot A,Greimers L,Drion P

    更新日期:2020-01-01 00:00:00

  • Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.

    abstract::Glycoprotein (GP) IIb-IIIa (αIIbβ3-integrin) is the central receptor of platelet aggregation. Activated GP IIb-IIIa binds fibrinogen or von Willebrand factor, which forms molecular bridges between aggregating platelets. This review summarizes data on the relationship between GP IIb-IIIa expression on the platelet surf...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.3109/09537104.2010.547959

    authors: Yakushkin VV,Zyuryaev IT,Khaspekova SG,Sirotkina OV,Ruda MY,Mazurov AV

    更新日期:2011-01-01 00:00:00

  • Tityus discrepans scorpion venom activates platelets through GPVI and a novel Src-dependent signaling pathway.

    abstract::In humans and other mammals, Tityus discrepans (Td) scorpion envenomation produces a variety of systemic effects including respiratory distress, a generalized inflammatory reaction, modulation of blood pressure, fibrin formation, and platelet activation. For many of these effects, the venom components and underlying m...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2010.544343

    authors: Brazón J,Hughes CE,Mori J,Sevcik C,D'suze G,Watson SP

    更新日期:2011-01-01 00:00:00

  • A deleterious effect of aspirin on the antithrombotic properties of endothelial cells is not observed with platelets previously exposed to aspirin: studies in a flow system.

    abstract::We have explored both the independent and combined effects of aspirin on cultured endothelial cells and platelets, and its influence on platelet deposition onto an extracellular matrix. Blood was circulated through a flat perfusion chamber with two coverslips placed sequentially with respect to blood flow. The first c...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109609079506

    authors: Alemany M,Hernández MR,Bozzo J,Bono A,Escolar G,Ordinas A,Bastida E

    更新日期:1996-01-01 00:00:00

  • Apoptotic markers in human blood platelets treated with peroxynitrite.

    abstract::Platelets are anucleated cells that upon activation by agonists or during storage may develop apoptotic events. The role of peroxynitrite and its reactive intermediates in apoptotic process in blood platelets is unknown. In order to study the appearance of biomarkers of apoptosis in platelets after treatment with pero...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100802406646

    authors: Wachowicz B,Rywaniak JZ,Nowak P

    更新日期:2008-12-01 00:00:00

  • Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study.

    abstract::The objective of this study was to obtain pilot data on which to judge the feasibility and sample size needed for a future comparative-effectiveness trial of platelet transfusions in the NICU. We conducted a limited-scope pilot trial in which neonates were randomized to receive platelet transfusions based on platelet ...

    journal_title:Platelets

    pub_type: 杂志文章,随机对照试验

    doi:10.3109/09537104.2013.843072

    authors: Zisk JL,Mackley A,Clearly G,Chang E,Christensen RD,Paul DA

    更新日期:2014-01-01 00:00:00

  • Efficacy of platelet concentrates in bone healing: A systematic review on animal studies - Part B: Large-size animal models.

    abstract::In the presence of large bone defects, delayed bone union, or nonunion and fractures, bone reconstruction may be necessary. Different strategies have been employed to enhance bone healing among which the use of autologous platelet concentrates (APCs). Due to the high content of platelets and platelet-derived bioactive...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537104.2017.1384537

    authors: Marcazzan S,Taschieri S,Weinstein RL,Del Fabbro M

    更新日期:2018-06-01 00:00:00

  • Assessment of bleeding disorders in Sheehan's syndrome: are bleeding disorders the underlying cause of Sheehan's syndrome?

    abstract::Sheehan's syndrome (SS) is an adenopituitary insufficiency caused by hypovolemia secondary to excessive blood loss during or after childbirth. However, the mechanism of postpartum hemorrhage and ischemia is not clear. We aimed to evaluate the bleeding disorders among patients with SS, in comparison with healthy contro...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2010.525722

    authors: Gokalp D,Tuzcu A,Bahceci M,Ayyildiz O,Erdemoglu M,Alpagat G

    更新日期:2011-01-01 00:00:00

  • Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy.

    abstract::Thrombocytopenia is a clinically relevant outcome in HIV. However, the epidemiology of this condition, including frequency, severity, and duration, has not been well-characterized in the era of highly active antiretroviral therapy (HAART). In this study, we describe the epidemiology of thrombocytopenia using two metho...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2011.582526

    authors: Vannappagari V,Nkhoma ET,Atashili J,Laurent SS,Zhao H

    更新日期:2011-01-01 00:00:00

  • Investigation of platelet function and platelet disorders using flow cytometry.

    abstract::Patients with thrombocytopenia or platelet disorders are at risk of severe bleeding. We report the development and validation of flow cytometry assays to diagnose platelet disorders and to assess platelet function independently of platelet count. The assays were developed to measure glycoprotein levels (panel 1) and p...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2015.1032919

    authors: Rubak P,Nissen PH,Kristensen SD,Hvas AM

    更新日期:2016-01-01 00:00:00

  • Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease.

    abstract::Activated platelets play a substantial role in Alzheimer's disease (AD) and atherothrombosis. Mean platelet volume (MPV) is an early marker of platelet activation, which is linked to a variety of pro-thrombotic and pro-inflammatory diseases. This study is to examine the association between platelet indices and vascula...

    journal_title:Platelets

    pub_type: 临床试验,杂志文章

    doi:10.3109/09537104.2013.831064

    authors: Liang QC,Jin D,Li Y,Wang RT

    更新日期:2014-01-01 00:00:00

  • Simultaneous genotyping of HPA-17w to -21w by PCR-SSP in Chinese Cantonese.

    abstract::Studies have reported the polymorphism of human platelet antigen (HPA)-17w, -18w, -19w, -20w, and -21w. However, the distribution of these five antigens in Chinese Cantonese is still unknown. In this study, we designed new sequence-specific primers for HPA-19w to -21w and used published primers for HPA-17w and -18w to...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2014.887668

    authors: Zhou H,Ding H,Chen Y,Li X,Ye X,Nie Y

    更新日期:2015-01-01 00:00:00

  • The role of platelet microvesicles in intercellular communication.

    abstract::In recent years, there has been exponential growth in the interest in microvesicles, which is reflected by the number of publications. Initially referred to as "platelet dust" by Peter Wolf in 1967, platelet microvesicles (PMV) are now recognized as important mediators of intercellular communication. There are example...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537104.2016.1257114

    authors: Edelstein LC

    更新日期:2017-05-01 00:00:00

  • Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity.

    abstract::Most agonists stimulate platelet Ca2+ rises via G-protein coupled receptors (GPCRs) or ITAM-linked receptors (ILRs). Well studied are the GPCRs stimulated by the soluble agonists thrombin (PAR1, PAR4), ADP (P2Y1, P2Y12), and thromboxane A2 (TP), signaling via phospholipase (PLC)β isoforms. The platelet ILRs glycoprote...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1859103

    authors: Fernández DI,Kuijpers MJE,Heemskerk JWM

    更新日期:2020-12-26 00:00:00

  • Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.

    abstract::Extracellular matrix metalloproteinase inducer (EMMPRIN; CD147), which binds to the platelet-specific collagen receptor glycoprotein (GP) VI, is expressed in a range of cell types including platelets and leukocytes, and has been implicated in neoplastic disease and atherosclerotic coronary disease. Both CD147 and GPVI...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2013.852660

    authors: Pennings GJ,Yong AS,Wong C,Al-Tamimi M,Gardiner EE,Andrews RK,Kritharides L

    更新日期:2014-01-01 00:00:00

  • Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

    abstract::A large number of patients require antiplatelet therapy (mainly aspirin and/or clopidogrel). Recent studies suggest that the combination of these agents is useful in patients with acute coronary syndrome and after percutaneous coronary intervention with stent placement. On the other hand, bleeding complications, most ...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537100500237004

    authors: Liberopoulos EN,Elisaf MS,Tselepis AD,Archimandritis A,Kiskinis D,Cokkinos D,Mikhailidis DP

    更新日期:2006-02-01 00:00:00

  • Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting.

    abstract::Bleeding in the setting of acute coronary syndromes (ACS) has negative prognostic implications. We sought to determine the impact of different levels of on-treatment platelet reactivity (PR) to ADP on both bleeding and ischemic events in ACS patients receiving coronary stenting. PR to ADP was measured with the VerifyN...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2011.568075

    authors: Huczek Z,Filipiak KJ,Kochman J,Michalak M,Roik M,Grabowski M,Opolski G

    更新日期:2011-01-01 00:00:00

  • Platelet-rich plasma in combination with bovine derived xenograft in the treatment of generalized aggressive periodontitis: a case report with re-entry.

    abstract::Prominence has been given recently to the use of platelet-rich plasma (PRP) in combination with bone graft materials for predictably obtaining periodontal regeneration through bioengineering. The purpose of this report was to present clinical, radiographic and re-entry results of a generalized aggressive periodontitis...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701481393

    authors: Yilmaz S,Cakar G,Kuru BE,Yildirim B

    更新日期:2007-11-01 00:00:00

  • Prostaglandin Regulation of Cyclic AMP Metabolism in Human Platelets.

    abstract::Prostaglandins stimulate cyclic AMP synthesis in platelets, leading to inhibition of platelet aggregation. Prostaglandin receptors have been identified but knowledge of their pharmacology is limited by the lack of antagonists. Kinetic measurements of prostaglandinregulated cyclic AMP formation provide useful informati...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109009009190

    authors: Ashby B

    更新日期:1990-01-01 00:00:00

  • The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.

    abstract::The aim of these studies was to investigate the extent of platelet P2Y(12) receptor inhibition by the thienopyridine active metabolite of prasugrel, R-138727. Blood was taken from healthy volunteers and pre-incubated with R-138727 or cangrelor (AR-C66931MX). Platelet aggregation was assessed in platelet rich plasma (P...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701694144

    authors: Judge HM,Buckland RJ,Sugidachi A,Jakubowski JA,Storey RF

    更新日期:2008-03-01 00:00:00

  • Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.

    abstract::The purpose of the study was to evaluate safety, effects on platelet aggregation and pharmacokinetics of F(ab')(2) fragments of anti-glycoprotein (GP) IIb-IIIa murine monoclonal antibody FRaMon (F(ab')(2) FRaMon) upon its intravenous administration in patients undergoing high-risk coronary angioplasty. Patients were t...

    journal_title:Platelets

    pub_type: 临床试验,杂志文章

    doi:10.1080/0953710021000057839

    authors: Mazurov AV,Pevzner DV,Antonova OA,Byzova TV,Khaspekova SG,Semenov AV,Vlasik TN,Samko AN,Staroverov II,Ruda MY

    更新日期:2002-12-01 00:00:00